[Chinese expert consensus on ocular surface diseases related to topical glaucoma medications (2022)]

Abstract

Glaucoma is a chronic progressive sight-threatening eye disease, so most patients need long-term or even lifelong medications. The ocular surface diseases caused by the use of topical glaucoma medications seriously affect the treatment compliance, the quality of life, and the treatment effects. In order to standardize the diagnosis and treatment of topical glaucoma medications-related ocular surface diseases, to improve the ocular surface health of patients and to effectively control the progress of glaucoma, the Glaucoma Group of Ophthalmology Branch of Chinese Medical Association has formulated this consensus after serious consideration and discussion. This evidence-based consensus puts forward suggestions on the characteristics, occurrence mechanism, risk factors, diagnosis, treatment, prevention and follow-up of ocular surface diseases associated with topical glaucoma medications.